Nomenclature
CAS number: 60282-87-3
(17α)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,15-dien-20-yn-3-one; 17α-ethynyl-17β-hydroxy-18-methyl-4,15-estradien-3-one; 17α-ethynyl-13-ethyl-17β-hydroxy-4,15-gonadien-3-one; SH B 331.
C
21H
26O
2; mol wt 310.43.
C 81.25%, H 8.44%, O 10.31%.
Description and references
Orally active gestogen with progesterone-like
profile of activity. Prepn: BE 847090; H. Hofmeister et al., US 4081537 (1977, 1978 both to Schering AG). Pharmacokinetics: B.
Duesterberg et al., Contraception 24, 673 (1981); B. Duesterberg, Steroids 43, 43 (1984). Comparative study
of anti-aldosterone activity: W. Losert et al., Arzneim.-Forsch. 35, 459 (1985).
Clinical trial as oral contraceptive: G. Hoppe, Adv. Contracept. 3, 159 (1987).
Properties
Crystals from acetone-hexane, mp 197.9°.Derivative
Mixture with ethinyl estradiol.
Nomenclature
CAS number: 109852-02-0
Femodene (Schering AG); Femovan (Schering AG); Ginoden (Schering AG); Gynera (Schering AG); Harmonet (Wyeth); Meliane (Schering AG); Milvane (Schering AG); Minulet (Wyeth); Phaeva (Schering AG); Tri-Minulet (Wyeth).
Therapeutic Category
Progestogen. In combination with estrogen as oral contraceptive.
Keywords
Contraceptive (Oral); Progestogen